Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in England. (2022)

First Author: Nafilyan V
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jamanetworkopen.2022.33446

PubMed Identifier: 36074469

Publication URI: http://europepmc.org/abstract/MED/36074469

Type: Journal Article/Review

Volume: 5

Parent Publication: JAMA network open

Issue: 9

ISSN: 2574-3805